Patents by Inventor Danny Thang Dinh

Danny Thang Dinh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 8-azaprostaglandin analogs as agents for lowering intraocular pressure
    Patent number: 6906097
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: June 14, 2005
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny Thang Dinh, Robert M. Burk
  • 8-Azaprostaglandin analogs as agents for lowering intraocular pressure
    Publication number: 20040157912
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; 1
    Type: Application
    Filed: April 9, 2003
    Publication date: August 12, 2004
    Inventors: David W. Old, Danny Thang Dinh, Robert M. Burk
  • 8-Azaprostaglandin analogs as agents for lowering intraocular pressure
    Publication number: 20030220506
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; 1
    Type: Application
    Filed: April 9, 2003
    Publication date: November 27, 2003
    Inventors: David W. Old, Danny Thang Dinh, Robert M. Burk
  • 8-azaprostaglandin analogs as agents for lowering intraocular pressure
    Patent number: 6573294
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: June 3, 2003
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny Thang Dinh, Robert M. Burk